|USA Edition||Today Is Tuesday December 10th, 2013|
|We know now that Government by organized money is just as dangerous as Government by organized mob - Franklin Delano Roosevelt|
|Browsing Materials Tagged Lane Labs||Organized In Date Order||[ 1 items ]|
|First Item||Middle Item||Last Item|
… the FTC originally charged Lane Labs with making unsupported and false claims that BeneFin and Skin Answer, a shark cartilage product and a skin cream, could prevent, treat, or cure cancer, and were clinically proven to do so. Lane Labs and Andrew Lane settled the charges by agreeing to a court order that barred them from making unsupported health claims about any food, drug, or dietary supplement.
Lane Labs Found In Contempt Of Court Order Barring Deceptive Health Claims
December 14, 2011
A federal judge has ruled in favor of the Federal Trade Commission, finding supplement marketer Lane Labs-USA Inc., and its president Andrew Lane in contempt of a court order that bars them from making deceptive health claims.
In 2000, the FTC originally charged Lane Labs with making unsupported and false claims that BeneFin and Skin Answer, a shark cartilage product and a skin cream, could prevent, treat, or cure cancer, and were clinically proven to do so. Lane Labs and Andrew Lane settled the charges by agreeing to a court order that barred them from making unsupported health claims about any food, drug, or dietary supplement.
In 2007, the FTC filed civil contempt charges against the defendants alleging that they violated the 2000 order based on their advertising and marketing of AdvaCAL, a calcium supplement the defendants touted as vastly superior to competing calcium products and prescription drugs used to treat osteoporosis. The charges were filed in the U.S. District Court for the District of New Jersey.
The district court ruled last month that the defendants violated the 2000 order by making unsupported claims that AdvaCAL is three-to-four times more absorbable than other calcium supplements, and distorting the results of tests and studies on AdvaCAL and competing calcium supplements. The district court also rejected the defendants’ claim that they substantially complied with the order, because their violations were not merely technical or inadvertent.
The recent decision follows an October 2010 ruling from the Third Circuit Court of Appeals overturning the district court’s original denial of the FTC’s contempt motion. The appeals court determined that the defendants had violated the order by making unsupported claims that AdvaCAL was comparable or superior to prescription drugs. The appeals court then sent the case back to the district court, which ruled last month that the defendants were in contempt. The district court will rule later on the amount of monetary damages for which the defendants are liable.
|Governance & Privacy|
|International Monetary Fund||Federal Reserve||European Central Bank||United Nations|
|Justice Department||State Department||Defense Department||Treasury Department||Transportation Department||Homeland Security Department||Commerce Department||Energy Department||Interior Department||Securities & Exchange Commission||Federal Trade Commission||National Institutes Of Health|
Seeing Is Believing
Thinking & AnalysisCritical Thinking
U.S. MilitaryAir Force
Legal & CourtsFederal Courts
Judgments & Opinions
House Of Representatives
Library Of Congress
United States Senate
HumanitiesBusiness Of Life
The Human Condition
OpinionCivility & Values
Conversations With America
Food For Thought
Contact UsOffer A Comment
Letters To The Editor
About UsAsk Newsroom
Errors & Omissions
Standards & PracticesCode Of Ethics
Government, Institutional And Commercial News Standards
Newsroom Magazine Founding Contributors
Newsroom Magazine USA Edition | Copyright © 2006 - 2013 Newsroom Publishing, Inc. | All Rights Reserved
Newsroom Magazine Is Powered By YourColo Data Power Station Servers
Newsroom Publishing Content Access Monitored By Tracker CMS Metrics
Data Power Station Load When This Page Was Delivered Was 11.09 % Of Allocated Power Station Capacity
SQL Queries For This Page = 153
Page Generation Time = 876 milliseconds